Don't sugar coat it: Safety of diabetes pharmacotherapy in patients with chronic kidney disease

1. Discuss the impact of medication errors and unsafe medication use encountered in the treatment of diabetes.
2. Identify strategies to mitigate risk for preferred glucose-lowering agents in patients with chronic kidney disease.
3. Describe a treatment plan for type 2 diabetes that considers patients' degree of renal impairment and additional patient-specific factors impacting safe medication use.

12:00 p.m. to 12:10 p.m.        Welcome & Pre-test  

12:10 p.m. to 12:50 p.m.        Program Presentation

12:50 p.m. to 1:00 p.m.         Post-test and Q & A

Program components are:

• Pre-test
  
• Presentation
  
• Post-test
• Question and Answer sessions

Achieving a passing score on the assessment post-test is not a requirement of obtaining continuing education credit; however, participating in all active learning components is.

Olivia Denny, PharmD

Ambulatory Care Residency/Buffalo Medical Group

University at Buffalo School of Pharmacy & Pharmaceutical Sciences

General Registration $25.00

We reserve the right to cancel this program due to such factors as insufficient registration. Registrants will be notified in this case. Requests for refunds, minus a $10 service charge, must be made in writing and will be honored up to one week prior to the program. After that time, no refunds will be provided.

Accreditaton information for pharmacists:

The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based activity has been awarded 1 contact hour or 0.1 ceu of live continuing pharmacy education credit.  Credit will be uploaded to the CPE Monitor for attendees who complete all components of the activity.

ACPE #0044-0000-24-005-L05-P

1 Contact Hr. or 0.1 CEU.

Please email questions to pharmacyce@buffalo.edu